Karius

Meet Karius

 

 

What would you do with the power of clarity?

 

Visit Karius at ASM Microbe 2019

At Karius, we are focused on helping clinicians diagnose infections, guide treatment, and ultimately improve patient care.

The Karius® Test is a non-invasive blood test based on next-generation sequencing of microbial cell-free DNA for pathogen detection. It can identify over 1,000 clinically relevant pathogens including bacteria, DNA viruses, fungi, and parasites. Applications include complicated pneumonia, endocarditis, and invasive fungal infections.

 

At ASM Microbe 2019, Karius will be presenting 5 abstracts and a presentation - see details below. Visit us at booth #5228!

 

 

ASM Microbe, June 20-24, 2019
Schedule-at-a-Glance

 

INDUSTRY SHOWCASE:

A Breakthrough in the Diagnosis of Infectious Diseases Using Microbial Cell-Free DNA

SATURDAY, JUNE 22 | 11:00 - 11:45 AM

 

Speakers 

  • James Dunn, PhD, D(ABMM) | Director of Medical Microbiology and Virology, Texas Children's Hospital | Professor, Pathology & Immunology, Baylor College of Medicine
  • John Farrell, MD | Director of Microbiology and Serology Labs, OSF System Laboratory | Professor, University of Illinois College of Medicine
  • Tim Blauwkamp, PhD | Chief Scientific Officer, Co-Founder | Karius

 

Program Description

Identifying the causative pathogen in infections remains challenging. Many pathogens are difficult to culture or require invasive biopsies and procedures for definitive diagnosis, and results are not always available in a clinically actionable timeframe. The Karius Test is a non-invasive blood test that uses next-generation sequencing of microbial cell-free DNA (mcfDNA) to identify over 1,000 clinically relevant bacteria, DNA viruses, fungi, and parasites that can cause infections throughout the body. 

Our approach based on mcfDNA offers a non-invasive alternative for diagnosing deep infections, results in higher diagnostic yields across patient types, and delivers faster time-to-diagnosis than routine methods. This session will review recently published data on the advantages of using mcfDNA for infectious disease diagnosis and present a clinical experience using the Karius Test in practice.

 

POSTER PRESENTATIONS:

FRIDAY, JUNE 21 | 11:00 AM -  12:00 PM & 4:00 PM - 5:00 PM

Poster CPHM-957
Next-generation Sequencing of Pathogen Cell-free DNA in Plasma (Karius Test) Reveals Nocardia Species Diversity in Clinical Infections
Presented by Asim Ahmed, MD | Karius 

 

SUNDAY, JUNE 23 | 11:00 AM -  1:00 PM

Poster CPHM-921
Evaluation of the Karius® Plasma Next Generation Sequencing Cell-free Pathogen DNA Test to Detect and Quantitate Cytomegalovirus, Epstein-Barr Virus, and BK Virus
Presented by Tim Blauwkamp, PhD | Karius

 

Poster CIV-170
Sequencing of Plasma Cell-Free DNA for Pathogen Detection in Prosthetic Joint Infections  
Presented by David Danko | Hospital for Special Surgery | Weill Cornell Medicine

 

Poster CIV-150
Detection of Bartonella Species in Culture-Negative Endocarditis Using the Karius Test, a Plasma Next-Generation Sequencing Test for Pathogen Detection
Presented by Asim Ahmed, MD | Karius

 

Poster CIV-135
Improving the clinical specificity of the unbiased Karius test via literature mining 
Presented by Lily Blair, PhD | Karius


To learn more about the Karius Test and how it can help your patients, please drop by booth #5228 or email info@kariusdx.com to schedule time with our Medical & Scientific Teams. 

We look forward to meeting you.

Meet Karius at ASM Microbe 2019
June 20-24, 2019
San Francisco, CA
Booth #5228